CASP1 and Bloom syndrome: While no statistical effect was noticed for the samples taken on day 7 (Supplementary Fig. S1f), HSM-pretreated mice showed markedly lower levels of caspase-1 mRNA than BLM–treated mice when analyzed on day 21 (Fig. 5a).